Questions for Genentech: Difference between revisions
Jump to navigation
Jump to search
(New page: ==Openness== * What sort of effect have NIH mandates, guidelines, or norms had on increasing or decreasing openness (i.e., a willingness to disclose data and narratives) ==Collaboration==...) |
|||
| Line 4: | Line 4: | ||
==Collaboration== | ==Collaboration== | ||
* What sort of informal networks exist between companies, universities, and investors, where data is shared for free? At what level of the value chain to they occur? | * What sort of informal networks exist between companies, universities, and investors, where data is shared for free? At what level of the value chain to they occur? | ||
* In what sense are universities collaborators and in what sense are they competitors? | |||
==Incentives to patent== | ==Incentives to patent== | ||
* What factors contribute to applying for a patent as opposed to simply publishing the findings? Do you ever patent products that you never plan to make money off of? | * What factors contribute to applying for a patent as opposed to simply publishing the findings? Do you ever patent products that you never plan to make money off of? | ||
Latest revision as of 21:13, 25 April 2009
Openness
- What sort of effect have NIH mandates, guidelines, or norms had on increasing or decreasing openness (i.e., a willingness to disclose data and narratives)
Collaboration
- What sort of informal networks exist between companies, universities, and investors, where data is shared for free? At what level of the value chain to they occur?
- In what sense are universities collaborators and in what sense are they competitors?
Incentives to patent
- What factors contribute to applying for a patent as opposed to simply publishing the findings? Do you ever patent products that you never plan to make money off of?